P371: HYPER-CVAD WITH SEQUENTIAL BLINATUMOMAB, WITH OR WITHOUT INOTUZUMAB OZOGAMICIN, IN ADULTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

• N. Short,
• H. Kantarjian,
• F. Ravandi,
• M. Yilmaz,
• T. Kadia,
• P. Thompson,
• X. Huang,
• M. Konopleva,
• A. Ferrajoli,
• N. Jain,
• K. Sasaki,
• Y. Alvarado,
• G. Borthakur,
• C. Dinardo,
• M. Ohanian,
• W. Macaron,
• S. Kornblau,
• M. Zhao,
• M. Kwari,
• C. Loiselle,
• R. Delumpa,
• A. Milton,
• J. Rivera,
• S. Lewis,
• R. Garris,
• E. Jabbour

Affiliations

N. Short

1 Department of Leukemia

H. Kantarjian

1 Department of Leukemia

F. Ravandi

1 Department of Leukemia

M. Yilmaz

1 Department of Leukemia

T. Kadia

1 Department of Leukemia

P. Thompson

1 Department of Leukemia

X. Huang

2 Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, United States of America

M. Konopleva

1 Department of Leukemia

A. Ferrajoli

1 Department of Leukemia

N. Jain

1 Department of Leukemia

K. Sasaki

1 Department of Leukemia

Y. Alvarado

1 Department of Leukemia

G. Borthakur

1 Department of Leukemia

C. Dinardo

1 Department of Leukemia

M. Ohanian

1 Department of Leukemia

W. Macaron

1 Department of Leukemia

S. Kornblau

1 Department of Leukemia

M. Zhao

1 Department of Leukemia

M. Kwari

1 Department of Leukemia

C. Loiselle

1 Department of Leukemia

R. Delumpa

1 Department of Leukemia

A. Milton

1 Department of Leukemia

J. Rivera

1 Department of Leukemia

S. Lewis

1 Department of Leukemia

R. Garris

1 Department of Leukemia

E. Jabbour

1 Department of Leukemia